• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

波兰溃疡性结肠炎患者肠道微生物失调:一项初步研究。

Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.

机构信息

Institute of Human Genetics, Polish Academy of Sciences, Strzeszynska 32, 60-479, Poznan, Poland.

Central Microbiology Laboratory, H. Swiecicki Clinical Hospital, Poznan University of Medical Sciences, Poznan, Poland.

出版信息

Sci Rep. 2021 Jan 25;11(1):2166. doi: 10.1038/s41598-021-81628-3.

DOI:10.1038/s41598-021-81628-3
PMID:33495479
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7835370/
Abstract

Ulcerative colitis (UC) is a chronic immune-mediated disorder, whose etiology is not fully understood and for which no effective treatment is available. Recently, research has focused on the dysbiosis of gut microbiome in UC. However, the results so far remain inconsistent and insufficient to understand the microbial component in UC pathogenesis. In this study, we determine specific changes in the gut microbial profile in Polish UC patients compared to healthy subjects for the first time. Using 16S rRNA gene-based analysis we have described the intestinal microbial community in a group of 20 individuals (10 UC patients and 10 controls). Our results after multiple hypothesis testing correction demonstrated substantially lower gut microbiome diversity in UC cases compared to the controls and considerable differences at the phylum level, as well as among 13 bacterial families and 20 bacterial genera (p < 0.05). UC samples were more abundant in Proteobacteria (8.42%), Actinobacteria (6.89%) and Candidate Division TM7 (2.88%) than those of healthy volunteers (2.57%, 2.29% and 0.012%, respectively). On the other hand, Bacteroidetes and Verrucomicrobia were presented at a lower level in UC relative to the controls (14% and 0% vs 27.97% and 4.47%, respectively). In conclusion, our results show a reduced gut microbial diversity in Polish UC patients, a reduction of taxa with an anti-inflammatory impact and an increased abundance of potentially pathogenic bacteria.

摘要

溃疡性结肠炎(UC)是一种慢性免疫介导的疾病,其病因尚未完全阐明,目前也没有有效的治疗方法。最近,研究集中在 UC 患者肠道微生物组的失调上。然而,迄今为止的研究结果仍然不一致,不足以了解微生物在 UC 发病机制中的作用。在这项研究中,我们首次确定了波兰 UC 患者与健康受试者之间肠道微生物谱的特定变化。我们使用基于 16S rRNA 基因的分析方法,描述了 20 名个体(10 名 UC 患者和 10 名对照)的肠道微生物群落。经过多次假设检验校正后,我们的结果表明,UC 患者的肠道微生物多样性明显低于对照组,而且在门水平以及 13 个细菌科和 20 个细菌属之间存在很大差异(p < 0.05)。UC 样本中变形菌门(8.42%)、放线菌门(6.89%)和候选门 TM7(2.88%)的丰度高于健康志愿者(分别为 2.57%、2.29%和 0.012%)。另一方面,与对照组相比,UC 患者中厚壁菌门和疣微菌门的丰度较低(分别为 14%和 0%,27.97%和 4.47%)。总之,我们的结果表明,波兰 UC 患者的肠道微生物多样性降低,具有抗炎作用的分类群减少,潜在致病性细菌的丰度增加。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e2e17ea42103/41598_2021_81628_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/2c6e3725483e/41598_2021_81628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/fa05bb5f81ed/41598_2021_81628_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/9f0b700c8cc9/41598_2021_81628_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/f285057e057d/41598_2021_81628_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/f78a61e80d2b/41598_2021_81628_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e193a30a4d45/41598_2021_81628_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e6275e1e0101/41598_2021_81628_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/fb8584ce44af/41598_2021_81628_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/3501af30507e/41598_2021_81628_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/11af55c26134/41598_2021_81628_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/becde04b7bf1/41598_2021_81628_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e2e17ea42103/41598_2021_81628_Fig12_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/2c6e3725483e/41598_2021_81628_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/fa05bb5f81ed/41598_2021_81628_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/9f0b700c8cc9/41598_2021_81628_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/f285057e057d/41598_2021_81628_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/f78a61e80d2b/41598_2021_81628_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e193a30a4d45/41598_2021_81628_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e6275e1e0101/41598_2021_81628_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/fb8584ce44af/41598_2021_81628_Fig8_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/3501af30507e/41598_2021_81628_Fig9_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/11af55c26134/41598_2021_81628_Fig10_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/becde04b7bf1/41598_2021_81628_Fig11_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8235/7835370/e2e17ea42103/41598_2021_81628_Fig12_HTML.jpg

相似文献

1
Dysbiosis of gut microbiota in Polish patients with ulcerative colitis: a pilot study.波兰溃疡性结肠炎患者肠道微生物失调:一项初步研究。
Sci Rep. 2021 Jan 25;11(1):2166. doi: 10.1038/s41598-021-81628-3.
2
Molecular profiling of mucosal tissue associated microbiota in patients manifesting acute exacerbations and remission stage of ulcerative colitis.溃疡性结肠炎急性发作和缓解期患者黏膜组织相关微生物群的分子特征分析。
World J Microbiol Biotechnol. 2018 May 23;34(6):76. doi: 10.1007/s11274-018-2449-0.
3
Analysis of endoscopic brush samples identified mucosa-associated dysbiosis in inflammatory bowel disease.分析内镜刷取样本发现炎症性肠病存在黏膜相关的菌群失调。
J Gastroenterol. 2018 Jan;53(1):95-106. doi: 10.1007/s00535-017-1384-4. Epub 2017 Aug 29.
4
Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis.溃疡性结肠炎患者的肠道菌群失调与全结肠炎的临床阶段。
Microbiologyopen. 2021 Mar;10(2):e1181. doi: 10.1002/mbo3.1181.
5
Fecal microbial dysbiosis in Chinese patients with inflammatory bowel disease.中国炎症性肠病患者的粪便微生物失调。
World J Gastroenterol. 2018 Apr 7;24(13):1464-1477. doi: 10.3748/wjg.v24.i13.1464.
6
Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis.肠道微生物群有助于溃疡性结肠炎两种中医证候的区分。
World J Gastroenterol. 2019 Jul 7;25(25):3242-3255. doi: 10.3748/wjg.v25.i25.3242.
7
Intestinal Taxa Abundance and Diversity in Inflammatory Bowel Disease Patients: An Analysis including Covariates and Confounders.炎症性肠病患者肠道分类群丰度和多样性:包括协变量和混杂因素的分析。
Nutrients. 2022 Jan 8;14(2):260. doi: 10.3390/nu14020260.
8
Adsorptive granulomonocytapheresis alters the gut bacterial microbiota in patients with active ulcerative colitis.吸附性粒细-单采术改变活动期溃疡性结肠炎患者的肠道细菌菌群。
J Clin Apher. 2021 Jun;36(3):454-464. doi: 10.1002/jca.21887. Epub 2021 Feb 18.
9
Partners of patients with ulcerative colitis exhibit a biologically relevant dysbiosis in fecal microbial metacommunities.溃疡性结肠炎患者的伴侣在粪便微生物群落中表现出具有生物学相关性的生态失调。
World J Gastroenterol. 2017 Jul 7;23(25):4624-4631. doi: 10.3748/wjg.v23.i25.4624.
10
Features of the gut microbiota in ulcerative colitis patients with depression: A pilot study.溃疡性结肠炎合并抑郁症患者肠道菌群特征的初步研究
Medicine (Baltimore). 2021 Feb 19;100(7):e24845. doi: 10.1097/MD.0000000000024845.

引用本文的文献

1
Probiotics in inflammatory bowel diseases: emphasis on mechanisms and clinical application.炎症性肠病中的益生菌:着重于作用机制及临床应用
Front Med (Lausanne). 2025 Aug 1;12:1620079. doi: 10.3389/fmed.2025.1620079. eCollection 2025.
2
New potential biomarkers of ulcerative colitis and disease course - integrated metagenomic and metabolomic analysis among Polish patients.溃疡性结肠炎及疾病进程的新潜在生物标志物——波兰患者的宏基因组与代谢组学综合分析
J Gastroenterol. 2025 Jul 4. doi: 10.1007/s00535-025-02280-6.
3
Impact of Psychopathology and Gut Microbiota on Disease Progression in Ulcerative Colitis: A Five-Year Follow-Up Study.

本文引用的文献

1
The Effectiveness of Multi-Session FMT Treatment in Active Ulcerative Colitis Patients: A Pilot Study.多疗程粪菌移植治疗活动性溃疡性结肠炎患者的有效性:一项初步研究。
Biomedicines. 2020 Aug 3;8(8):268. doi: 10.3390/biomedicines8080268.
2
Ranking microbiome variance in inflammatory bowel disease: a large longitudinal intercontinental study.炎症性肠病中微生物组变异的排序:一项大型的纵向洲际研究。
Gut. 2021 Mar;70(3):499-510. doi: 10.1136/gutjnl-2020-321106. Epub 2020 Jun 14.
3
Gut microbiota in ulcerative colitis: insights on pathogenesis and treatment.
精神病理学和肠道微生物群对溃疡性结肠炎疾病进展的影响:一项五年随访研究
Microorganisms. 2025 May 25;13(6):1208. doi: 10.3390/microorganisms13061208.
4
[1]The human gut microbiota in IBD, characterizing hubs, the core microbiota and terminal nodes: a network-based approach.[1]炎症性肠病中的人体肠道微生物群,表征枢纽、核心微生物群和终端节点:一种基于网络的方法。
BMC Microbiol. 2025 Jun 26;25(1):371. doi: 10.1186/s12866-025-04106-0.
5
Microbiome Markers in Gastrointestinal Disorders: Inflammatory Bowel Disease, Colorectal Cancer, and Celiac Disease.胃肠道疾病中的微生物组标志物:炎症性肠病、结直肠癌和乳糜泻
Int J Mol Sci. 2025 May 17;26(10):4818. doi: 10.3390/ijms26104818.
6
Genomic insights into novel predatory myxobacteria isolated from human feces.从人类粪便中分离出的新型捕食性粘细菌的基因组见解。
Microbiol Spectr. 2025 Jul;13(7):e0214724. doi: 10.1128/spectrum.02147-24. Epub 2025 May 22.
7
Qing-Re-Hua-Shi Decoction ameliorates DSS-induced colitis by modulating multiple signaling pathways and remodeling the gut microbiota and metabolite profile.清热化湿汤通过调节多种信号通路以及重塑肠道微生物群和代谢物谱来改善右旋糖酐硫酸钠诱导的结肠炎。
Front Cell Infect Microbiol. 2025 Apr 2;15:1541289. doi: 10.3389/fcimb.2025.1541289. eCollection 2025.
8
Effects of Short Chain Fatty Acid-Butyrate Supplementation on the Disease Severity, Inflammation, and Psychological Factors in Patients With Active Ulcerative Colitis: A Double-Blind Randomized Controlled Trial.补充短链脂肪酸丁酸对活动期溃疡性结肠炎患者疾病严重程度、炎症及心理因素的影响:一项双盲随机对照试验
J Nutr Metab. 2025 Mar 16;2025:3165876. doi: 10.1155/jnme/3165876. eCollection 2025.
9
The role of gut microbiota and plasma metabolites in ulcerative colitis: Insights from Mendelian randomization analysis.肠道微生物群和血浆代谢物在溃疡性结肠炎中的作用:孟德尔随机化分析的见解
Medicine (Baltimore). 2025 Feb 28;104(9):e41710. doi: 10.1097/MD.0000000000041710.
10
Dental problems and oral microbiome alterations in ulcerative colitis.溃疡性结肠炎中的牙齿问题与口腔微生物群改变
Front Immunol. 2025 Feb 5;16:1502605. doi: 10.3389/fimmu.2025.1502605. eCollection 2025.
溃疡性结肠炎中的肠道微生物群:发病机制和治疗的新见解。
J Dig Dis. 2020 Mar;21(3):147-159. doi: 10.1111/1751-2980.12849.
4
Microbial imbalance in inflammatory bowel disease patients at different taxonomic levels.炎症性肠病患者在不同分类水平上的微生物失衡。
Gut Pathog. 2020 Jan 4;12:1. doi: 10.1186/s13099-019-0341-6. eCollection 2020.
5
Differences in Gut Microbiota in Patients With vs Without Inflammatory Bowel Diseases: A Systematic Review.炎症性肠病患者与非炎症性肠病患者的肠道微生物群差异:系统评价。
Gastroenterology. 2020 Mar;158(4):930-946.e1. doi: 10.1053/j.gastro.2019.11.294. Epub 2019 Dec 5.
6
Alteration of Gut Microbiota in Inflammatory Bowel Disease (IBD): Cause or Consequence? IBD Treatment Targeting the Gut Microbiome.炎症性肠病(IBD)中肠道微生物群的改变:原因还是后果?针对肠道微生物群的IBD治疗靶点
Pathogens. 2019 Aug 13;8(3):126. doi: 10.3390/pathogens8030126.
7
Microbial Population Changes and Their Relationship with Human Health and Disease.微生物种群变化及其与人类健康和疾病的关系。
Microorganisms. 2019 Mar 3;7(3):68. doi: 10.3390/microorganisms7030068.
8
What is the Healthy Gut Microbiota Composition? A Changing Ecosystem across Age, Environment, Diet, and Diseases.健康的肠道微生物群组成是怎样的?一个随年龄、环境、饮食和疾病变化的生态系统。
Microorganisms. 2019 Jan 10;7(1):14. doi: 10.3390/microorganisms7010014.
9
A comparative study of the gut microbiota in immune-mediated inflammatory diseases-does a common dysbiosis exist?免疫介导的炎症性疾病的肠道微生物组比较研究——是否存在共同的菌群失调?
Microbiome. 2018 Dec 13;6(1):221. doi: 10.1186/s40168-018-0603-4.
10
The role of the microbiome for human health: from basic science to clinical applications.微生物组对人类健康的作用:从基础科学到临床应用。
Eur J Nutr. 2018 May;57(Suppl 1):1-14. doi: 10.1007/s00394-018-1703-4.